# CTX, known FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/ctx-known

> No upcoming FDA catalysts in CTX, known; 2 past events are recorded.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only, exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### What are the upcoming FDA decisions for CTX, known?

No upcoming FDA catalysts in CTX, known; 2 past events are recorded. Press release filed with the SEC (EX-99): "•PDUFA date for chenodiol in CTX is December 28, 2024" [Calendar and source filings](https://sec-api.dev/indications/ctx-known)

Source: Press release filed with the SEC (EX-99), accession 0001759425-24-000037, https://www.sec.gov/Archives/edgar/data/1759425/000175942524000037/mirm-20241112xexx991.htm (retrieved 2026-11-12). Last confirmed 2024-11-12. Cite: https://sec-api.dev/indications/ctx-known#answer

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Jun 2024 | [Chenodal (chenodal) NDA/BLA acceptance](https://sec-api.dev/pdufa/chenodal) | MIRM | CTX, known | completed | "We announced topline results of a Phase 3 clinical trial to evaluate the effects of Chenodal in patients with CTX, known as the RESTORE clinical trial, which we used to support our NDA submission in June 2024 for marketing authorization of Chenodal for CTX in the U.S. The FDA has accepted the NDA submission and has assigned a PDUFA date of December 28, 2024." ([SEC Form 10-Q](https://www.sec.gov/Archives/edgar/data/1759425/000175942524000038/mirm-20240930.htm)) |
| December 28, 2024 | [CTEXLI® (chenodiol) PDUFA date](https://sec-api.dev/pdufa/chenodiol) | MIRM | CTX, known | scheduled | "•PDUFA date for chenodiol in CTX is December 28, 2024" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1759425/000175942524000037/mirm-20241112xexx991.htm)) |

## Drugs

- [Chenodal (chenodal)](https://sec-api.dev/pdufa/chenodal) (MIRM)
- [CTEXLI® (chenodiol)](https://sec-api.dev/pdufa/chenodiol) (MIRM)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/ctx-known.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "CTX, known FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/ctx-known

```bibtex
@misc{secapidev_indications_ctx_known_20261116,
  title        = {CTX, known FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/ctx-known}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_ctx_known_20261116","title":"CTX, known FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/ctx-known","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
